Could the nerve cells that scratch be the solution for itch?

 It can be a relief to scratch the occasional itch, but when itch gets out of control, it can become a serious health problem. How does the body know when to stop?

Scientists at UC San Francisco are getting close to an answer. In a breakthrough that could transform how doctors treat conditions from eczema to allergies, they have discovered a feedback loop centered on a single immune protein called IL-31 that both causes the urge to itch and dials back nearby inflammation.

The findings, published on October 13th in Science Immunology, lay the groundwork for a new generation of drugs that interact more intelligently with the body's innate ability to self-regulate.

Previous approaches suggested that IL-31 signals itch and promotes skin inflammation. But the UCSF team discovered that nerve cells, or neurons, that respond to IL-31, triggering a scratch, also prevent immune cells from overreacting and causing more widespread irritation.

"We tend to think that immune proteins like IL-31 help immune cells talk to one another, but here, when IL-31 talks to neurons, the neurons talk right back," said Marlys Fassett, M.D., Ph.D., UCSF professor of dermatology and lead author of the study. "It's the first time we've seen the nervous system directly tamp down an allergic response."

The discovery could eventually change how asthma, Crohn's and other inflammatory diseases are treated, due to IL-31's presence throughout the body.

"IL-31 causes itch in the skin, but it's also in the lung and in the gut," said Mark Ansel, Ph.D., UCSF professor of immunology and senior author of the study. "We now have a new lead for fighting the many diseases involving both the immune and nervous systems."

More than an itch

IL-31 is one of several "itch cytokines" because of its ability to instigate itch in animals and people. Fassett, a dermatologist and a researcher, has wanted to know why since she arrived at UCSF in 2012, a few years after its discovery. She reached out to Ansel, a former colleague and asthma expert who welcomed her into his lab.

First, Fassett removed the IL-31 gene from mice and exposed them to the house dust mite, a common, itchy allergen.

"We wanted to mimic what was actually happening in people who are chronically exposed to environmental allergens," Fassett said. "As we expected, the dust mite didn't cause itching in the absence of IL-31, but we were surprised to see that inflammation went up."

Why was there inflammation but no itching? Fassett and Ansel found that a cadre of immune cells had been called into action in the absence of the itch cytokine. Without IL-31, the body was blindly waging an immunological war.

A balance of forces

Ansel and Fassett then homed in on the nerve cells in the skin that received the IL-31 signal. They saw that the same nerve cells that spurred a scratch also dampened any subsequent immune response. These nerve cells were integral to keeping inflammation in check, but without IL-31, they let the immune system run wild.

Source: ScienceDaily